Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
Accord Healthcare is one of the fastest growing generic pharmaceutical companies in Ireland and the UK.
Acquiring Actavis Ireland and the UK in 2017 facilitates Accord’s ambition of becoming a top 5 pan-EMEA generics company by 2020 and a leading player in the industry at European level.
Accord has one of the most extensive sales, marketing and distribution networks in Europe. Accord now supplies products in close to 65 EMENA markets.
Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
Accord Healthcare is delighted to announce the launch of another High-Tech medicine to their already extensive range of High-Tech medicines, Lenalidomide Accord 5 mg, 10 mg, 15 mg, 20 mg & 25 mg which come in pack sizes of 21 Hard Capsules.
Accord Healthcare is delighted to announce the launch of another High-Tech medicine to their already extensive portfolio of High-Tech medicines: Icatibant Accord 30 mg which comes in a pack of one 3 ml pre-filled syringe.